Wija Oortwijn

Wija Oortwijn is a researcher at Radboud University's Department of Health Evidence, specializing in Health Technology Assessment (HTA). She serves as Vice-President of Health Technology Assessment International (HTAi) since 2019, a role expected to evolve into President in future terms. Her expertise spans over two decades in HTA, infectious diseases, and global health policy.

Her research focuses on improving diagnostic reliability and treatment cost-effectiveness, as evidenced by the VICTORY study evaluating Lyme disease diagnostics and analyses of antibiotic regimens. She actively contributes to international health networks and policy decisions, including citizen forums on healthcare coverage criteria.

No scientific awards or grants are explicitly mentioned in the provided texts. Her professional trajectory includes leadership roles without indication of part-time status or retirement.